Company intelligence / Profile preview

MERLIN Diagnostika

Ownership: Private
Development stage: Other

Overview

MERLIN Diagnostika specializes in automated identification and susceptibility testing of bacteria and yeast, as well as enhancing automated environmental monitoring in isolator technology. The company has over 30 years of experience in manufacturing antimicrobial susceptibility testing (AST) products, with facilities certified according to ISO 13485. MERLIN also offers third-party manufacturing services including consumable testing, antibiotic solution preparation, filling, drying, quality control, and packaging for diagnostic systems.

Therapeutic areas: Infectious Diseases
Modalities: Diagnostic testAntibiotic susceptibility test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on MERLIN Diagnostika.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MERLIN Diagnostika.

Explore the full profile